LABEL-FREE ARRAY SYSTEMS MARKET ANALYSIS
Market Trends
Increasing adoption of label-free array systems in the drug discovery process is expected to drive the global label-free array systems market growth over the forecast period. For instance, according to the National center for Biotechnology Information, (NCBI), 2016, label-free array systems are extensively used for secondary screening to find the lead molecule for the drug development process from the small molecule hits and it is also used for lead optimization to find the candidate drug from the leads molecules. Moreover, according to the same source, currently the label-free array systems are extensively used for evaluating kinetics between the drug molecule and its receptor, as it is most important bond that is characterized for drug discovery process.
Leading manufacturers are focused on manufacturing new products in the global label-free array systems market over the forecast period. For instance, in 2018, Bruker Corporation launched a modified version of SPR, Sierra SPR-32 system, with higher sensitivity, modified instrument control software to enable highest SPR throughput with outstanding sensitivity. These factors are expected to drive the global label-free array systems market growth over the forecast period.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
